The Aortic Stenosis Market is estimated at US$10.8 billion in 2026 and is projected to grow at a CAGR of 10.8% to reach US$24.5 billion by 2034.
Its value chain includes imaging providers, valve device manufacturers, hospitals, cardiologists, surgeons, rehabilitation providers, and payer systems. Core applications include structural heart intervention, transcatheter valve replacement, surgical valve replacement, diagnostic imaging, hospital cardiology care, and chronic follow up management.
This product will be delivered within 1-3 business days.
Market Overview
The Aortic Stenosis Market covers diagnostic, interventional, surgical, and long term management solutions used to identify and treat narrowing of the aortic valve across cardiology and structural heart care settings.Its value chain includes imaging providers, valve device manufacturers, hospitals, cardiologists, surgeons, rehabilitation providers, and payer systems. Core applications include structural heart intervention, transcatheter valve replacement, surgical valve replacement, diagnostic imaging, hospital cardiology care, and chronic follow up management.
Key Companies Analysed
- Edwards Lifesciences
- Medtronic
- Abbott
- Boston Scientific
- LivaNova
- JenaValve
- Meril Life Sciences
- J&J MedTech
- Siemens Healthineers
- GE HealthCare
- Philips
- Artivion
- CryoLife
- HighLife
- Peijia Medical
- Venus Medtech
- MicroPort
- JC Medical
- Bracco
- Cardiovalve
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Aortic Stenosis Market Overview
3. Aortic Stenosis Market Dynamics
4. Aortic Stenosis Market Strategic Analysis
5. Global Aortic Stenosis Market Size, Share and Forecast, 2025-2034
6. North America Aortic Stenosis Market Outlook to 2034
7. Europe Aortic Stenosis Market Outlook to 2034
8. Asia-Pacific Aortic Stenosis Market Outlook to 2034
9. Middle East and Africa Aortic Stenosis Market Outlook to 2034
10. South and Central America Aortic Stenosis Market Outlook to 2034
11. Aortic Stenosis Market Competitive Landscape
12. Appendix
Companies Mentioned
- Edwards Lifesciences
- Medtronic
- Abbott
- Boston Scientific
- LivaNova
- JenaValve
- Meril Life Sciences
- J&J MedTech
- Siemens Healthineers
- GE HealthCare
- Philips
- Artivion
- CryoLife
- HighLife
- Peijia Medical
- Venus Medtech
- MicroPort
- JC Medical
- Bracco
- Cardiovalve
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 10.8 Billion |
| Forecasted Market Value ( USD | $ 24.5 Billion |
| Compound Annual Growth Rate | 10.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
